Actively Recruiting

Age: 18Years +
All Genders
NCT06940102

Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors

Led by Changchun GeneScience Pharmaceutical Co., Ltd. · Updated on 2025-04-23

120

Participants Needed

2

Research Sites

89 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is a prospective, observational clinical study aimed at evaluating the efficacy of Megestrol Acetate for cachexia in patients with advanced digestive system tumors receiving TKI-based therapy.

CONDITIONS

Official Title

Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Voluntarily sign a written informed consent
  • Age 18 years or older at enrollment
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
  • Life expectancy of 3 months or more
  • Histologically or cytologically confirmed locally advanced or metastatic digestive system tumors not suitable for curative treatment
  • Not benefiting from local anticancer therapies and planned to receive TKI-based anticancer treatment (possibly combined with chemotherapy or immunotherapy)
  • Meet diagnostic criteria for pre-cachexia or cachexia based on Fearon criteria
  • Good organ function
Not Eligible

You will not qualify if you...

  • Gastrointestinal obstruction
  • Anorexia caused by difficulty eating due to neurosis, mental illness, or pain
  • Severe cerebrovascular, cardiac, renal, or liver diseases
  • Major surgery or trauma within the last month
  • Allergy to any component of the investigational drug
  • Other conditions deemed unsuitable by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

General Hospital of Northern Theater Command

Shenyang, Liaoning, China, 110016

Actively Recruiting

2

Liaoning Cancer Hospital

Shenyang, Liaoning, China, 110042

Actively Recruiting

Loading map...

Research Team

C

Cheng Du

CONTACT

Z

Zhenguang Du

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here